Wockhardt secures CDSCO panel conditional nod to conduct Phase IV Trial of Levonadifloxacin MD Bureau6 Jan 2021 6:18 PM ISTNew Delhi: Pharmaceutical and biotechnology major Wockhardt Ltd. has recently secured permission from the Subject Expert Committee (SEC) of the...
AIDAN slams approval of Covaxin, expresses alarm over lack of efficacy, trial data Farhat Nasim5 Jan 2021 4:42 PM ISTNew Delhi: Slamming the recent approval of Covid-19 vaccine, Covaxin, developed by Bharat Biotech in association with the Indian Council of...
CDSCO panel directs Themis Medicare to conduct blinded trial of Inosine Pranobex in Moderate Covid-19 patient MD Bureau3 Jan 2021 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) recently recommended Themis...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 4:56 PM ISTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
Eli Lilly gets CDSCO Committee nod for marketing authorization for Insulin Lispro MD Bureau1 Jan 2021 6:17 PM ISTNew Delhi: In a major rejoice to Eli Lilly and Company (India) Pvt. Ltd., the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Pharmaceutical Medico-Marketing: In the COVID-19 Era and Beyond Meghna A Singhania31 Dec 2020 11:42 AM ISTThe COVID-19 pandemic has led to unprecedented changes in every facet of civilization and the pharmaceutical industry has been no different from...
CDSCO panel asks Hetero to resubmit Bioequivalence protocol for Trelagliptin Succinate tablet MD Bureau30 Dec 2020 7:12 PM ISTNew Delhi: Noting that the protocol was not scientifically designed and the safety of the study subjects was not taken care of, the Subject Expert...
CDSCO mandates license for import, manufacture of nebulizers, BP monitoring devices, digital thermometers, glucometer Ruchika Sharma29 Dec 2020 6:18 PM ISTNew Delhi: Through a recent notification the Central Drugs Standard Control Organization (CDSCO) has made it mandatory for importers and manufacturers...
Serum Institute unveils India first fully indigenous pneumococcal vaccine "Pneumosil" MD Bureau28 Dec 2020 4:50 PM ISTThe vaccine will provide effective and long-lasting protection for children against pneumococcal diseases.
CDSCO Declares 14 Drug Samples Including BP, dyslipidemia Drug As Not Of Standard Quality Ruchika Sharma27 Dec 2020 11:30 AM ISTNew Delhi: The apex drug regulatory body, Central Drugs Standard Organization (CDSCO) has flagged 14 drug samples as "Not of Standard Quality" after...
Covid virus will stay with us for next 10 years: BioNTech CEO MD Bureau26 Dec 2020 12:43 PM ISTLondon: As the world grapples with the pandemic amid the origin of newer and potentially lethal strains, BioNTech CEO Ugur Sahin has said that...
CDSCO panel rejects Emcure Voglibose, Vildagliptin FDC citing dosage schedule incompatibility between ingredients Farhat Nasim25 Dec 2020 1:18 PM ISTNew Delhi: Citing dosage schedule incompatibility between the ingredients, the Subject Expert Committee (SEC) functional under the Central Drugs...
